新宙邦(300037.SZ):將向Ultium Cells供應約3.67億美元鋰離子電池電解液
格隆匯11月11日丨新宙邦(300037.SZ)公佈,2021年11月9日,公司與Ultium Cells, LLC 簽訂了供貨合同,約定自合同簽訂日至2025年末由公司向Ultium Cells, LLC 供應鋰離子電池電解液產品,合同金額約3.67億美元。
公吿顯示,Ultium Cells, LLC 是LG Energy Solution和通用汽車公司共同投資設立的合資企業,總投資額為23億美元,主營業務為電動車用鋰電池的生產製造。
該合同的簽訂,標誌着公司在鋰離子電池電解液產品海外市場開拓方面取得積極進展,確保了未來在北美市場的訂單需求,也為公司在美國市場的佈局奠定了基礎,有助於進一步提升公司的盈利能力,鞏固公司在國際市場中的競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.